- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 3 Oct 23 424B4 Prospectus supplement with pricing info
- 2 Oct 23 EFFECT Notice of effectiveness
- 28 Sep 23 S-1/A IPO registration (amended)
-
22 Sep 23 S-1/A IPO registration (amended)
- 11 Sep 23 S-1/A IPO registration (amended)
- 5 Sep 23 S-1/A IPO registration (amended)
- 31 Jul 23 FWP Free writing prospectus
- 27 Jul 23 S-1/A IPO registration (amended)
- 12 Jul 23 S-1 IPO registration
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Intelligent Bio Solutions Inc.
New York, New York
We hereby consent to the use in the Prospectus constituting a part of the Registration Statement on Form S-1 of our report dated September 21, 2022, except for the effects of the reverse stock split discussed in Note 3 and effects of the change in the segments discussed in Note 4, as to which the date is August 23, 2023, relating to the consolidated financial statements of Intelligent Bio Solutions Inc. (f/k/a GBS Inc.). Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption ‘Experts’ in this Prospectus.
/s/ BDO Audit Pty Ltd
Sydney, Australia
September 22, 2023